Stay updated on BTD-001 in IH & Narcolepsy Type 2 Clinical Trial
Sign up to get notified when there's something new on the BTD-001 in IH & Narcolepsy Type 2 Clinical Trial page.

Latest updates to the BTD-001 in IH & Narcolepsy Type 2 Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedLocations are now listed under a single Locations section, detailing sites by state (Alabama, California, Colorado, Florida, Georgia, Kentucky, Maryland, Massachusetts, Minnesota, Missouri, New York, North Carolina, Ohio, Oklahoma, South Carolina, Texas, Washington).SummaryDifference2%

- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedThe site revision was updated from v3.2.0 to v3.3.2. No trial data, eligibility rules, contacts, or locations were changed.SummaryDifference0.0%

- Check52 days agoChange DetectedRemoved the government funding status notice from the page; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check67 days agoChange DetectedThe new screenshot preserves the Study Details page structure and data fields (Overview, Eligibility Criteria, Locations, and Outcomes) with no substantive content changes. No significant updates are detected.SummaryDifference0.3%

- Check95 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference5%

- Check103 days agoChange DetectedThe page has been updated to version v3.1.0 and several related topics (MedlinePlus topics on drug safety and counterfeit/substandard drugs) have been removed. Overall, this is a minor, metadata-level update with no new core content or time-sensitive information added.SummaryDifference0.8%

Stay in the know with updates to BTD-001 in IH & Narcolepsy Type 2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BTD-001 in IH & Narcolepsy Type 2 Clinical Trial page.